Avanos Medical AVNS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $89.8M-16.6% | $107.7M+22.8% | $87.7M-31.3% | $127.7M+7.8% | ||
| $103.8M-21.8% | $132.8M-7.0% | $142.8M-14.9% | $167.9M+28.0% | ||
| $148M+6.6% | $138.8M-15.0% | $163.2M+23.4% | $132.3M-16.9% | ||
| $355.4M-9.7% | $393.4M-19.2% | $487M-22.0% | $624.1M+46.0% | ||
| $113.4M+2.4% | $110.7M-5.5% | $117.2M-1.2% | $118.6M-29.4% | ||
| $394.9M-13.3% | $455.6M-42.8% | $796.1M+4.7% | $760.3M+2.4% | ||
| $117.8M+4.9% | $112.3M-53.1% | $239.5M+2.3% | $234.2M+65.9% | ||
| $1.07B-7.0% | $1.15B-31.8% | $1.69B-5.3% | $1.79B+11.4% | ||
| $55.5M+2.2% | $54.3M-3.6% | $56.3M-17.1% | $67.9M+20.4% | ||
| $10.2M+8.5% | $9.4M+9.3% | $8.6M+38.7% | $6.2M— | ||
| $165.2M-0.4% | $165.9M-29.3% | $234.6M+22.8% | $191M+37.2% | ||
| $90.3M-27.9% | $125.3M-21.4% | $159.4M-29.6% | $226.3M+74.1% | ||
| $295.5M-9.3% | $325.7M-28.6% | $456.1M-8.0% | $495.7M+48.9% | ||
| 300M+59,900% | 500K0.0% | 500K0.0% | 500K0.0% | ||
| -$779.9M-10.3% | -$707M-125% | -$314.9M-24.4% | -$253.1M+16.6% | ||
| $778.2M-6.1% | $828.5M-33.0% | $1.24B-4.3% | $1.29B+1.6% | ||
| $1.07B-7.0% | $1.15B-31.8% | $1.69B-5.3% | $1.79B+11.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avanos Medical's total assets?
- Avanos Medical (AVNS) holds $1.1B in total assets, down 5.2% year over year.
- How much debt does Avanos Medical have?
- Avanos Medical carries $138.4M in total debt against $782.1M of shareholders' equity, a debt-to-equity ratio of 0.18.
- How much cash does Avanos Medical have?
- Avanos Medical holds $65.6M in cash and equivalents.
- Can Avanos Medical cover its short-term obligations?
- Its current ratio is 2.48 — current assets exceed current liabilities.
- Where does Avanos Medical's balance sheet data come from?
- Every line is extracted from Avanos Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
